The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-N-[(4,6-Dimethoxy-1H-indol-2-yl)methyl]-1-(1-naphthyl)ethanamine ID: ALA3752334
PubChem CID: 57385840
Max Phase: Preclinical
Molecular Formula: C23H24N2O2
Molecular Weight: 360.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(OC)c2cc(CN[C@H](C)c3cccc4ccccc34)[nH]c2c1
Standard InChI: InChI=1S/C23H24N2O2/c1-15(19-10-6-8-16-7-4-5-9-20(16)19)24-14-17-11-21-22(25-17)12-18(26-2)13-23(21)27-3/h4-13,15,24-25H,14H2,1-3H3/t15-/m1/s1
Standard InChI Key: BFVSPBVBARMDKY-OAHLLOKOSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-1.2896 2.9981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3263 3.6026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0131 3.7434 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0200 5.2442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4761 7.4707 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3227 5.9895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6465 5.3679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6674 6.4577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1709 6.4182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9455 7.7257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2184 9.0320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6990 9.0627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9403 7.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9951 10.3162 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4171 11.3678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8957 5.1043 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0954 5.0801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 1
1 3 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
4 13 2 0
8 13 1 0
1 4 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
15 23 1 0
18 23 2 0
24 25 1 0
21 24 1 0
26 27 1 0
19 26 1 0
14 16 1 0
3 14 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 360.46Molecular Weight (Monoisotopic): 360.1838AlogP: 5.19#Rotatable Bonds: 6Polar Surface Area: 46.28Molecular Species: BASEHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.89CX LogP: 4.37CX LogD: 2.87Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.50Np Likeness Score: -0.43
References 1. Kiefer L, Beaumard F, Gorojankina T, Faure H, Ruat M, Dodd RH.. (2016) Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists., 24 (4): [PMID:26752095 ] [10.1016/j.bmc.2015.12.019 ]